Literature DB >> 9550325

Phenotypical and functional characterization of Herpesvirus saimiri-immortalized human major histocompatibility complex class II-deficient T lymphocytes.

D Alvarez-Zapata1, S de Miguel Olalla, G Fontán, A Ferreira, M C García-Rodríguez, L Madero, P van den Elsen, J R Regueiro.   

Abstract

CD8+ T lymphocytes from two unrelated cases of MHC class II deficiency were immortalized in vitro using Herpesvirus saimiri. In both cases, a lack of expression of surface MHC class II molecules was ascertained, whereas variable defects were shown for MHC class I, CD74 (invariant chain) and LAG-3 (an MHC class II ligand). The functional analysis of both H. saimiri-immortalized T-cell lines revealed the existence of a proliferation impairment in response to anti-CD3 but not to other surface or transmembrane stimuli. Further characterization of this functional defect indicated that it was not associated with impaired early activation events (like calcium flux) but, rather, with certain late events, like the induction of IL-2. H. saimiri-immortalized T cells may be valuable in studying the biological role of MHC class II molecules in activated human T cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9550325     DOI: 10.1111/j.1399-0039.1998.tb03099.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  2 in total

Review 1.  Herpesvirus saimiri.

Authors:  H Fickenscher; B Fleckenstein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

2.  Human CD3γ, but not CD3δ, haploinsufficiency differentially impairs γδ versus αβ surface TCR expression.

Authors:  Miguel Muñoz-Ruiz; Verónica Pérez-Flores; Beatriz Garcillán; Alberto C Guardo; Marina S Mazariegos; Hidetoshi Takada; Luis M Allende; Sara S Kilic; Ozden Sanal; Chaim M Roifman; Eduardo López-Granados; María J Recio; Eduardo Martínez-Naves; Edgar Fernández-Malavé; José R Regueiro
Journal:  BMC Immunol       Date:  2013-01-21       Impact factor: 3.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.